Grigg A - Search Results

1

Abbreviated dose rituximab for immune-mediated hematological disorders.

Fairweather H, Tuckfield A, Grigg A. Fairweather H, et al. Among authors: grigg a. Am J Hematol. 2008 Jul;83(7):554-7. doi: 10.1002/ajh.21143. Am J Hematol. 2008. PMID: 18314916 Free article.

2

Severe intravascular hemolysis associated with interferon treatment for chronic myeloid leukemia.

Tuckfield A, Metz J, Grigg A. Tuckfield A, et al. Among authors: grigg a. Am J Hematol. 1996 Sep;53(1):52-3. doi: 10.1002/(SICI)1096-8652(199609)53:1<52::AID-AJH15>3.0.CO;2-5. Am J Hematol. 1996. PMID: 8813104 Free article. No abstract available.

3

Reduction of inappropriate use of blood products by prospective monitoring of transfusion request forms.

Tuckfield A, Haeusler MN, Grigg AP, Metz J. Tuckfield A, et al. Among authors: grigg ap. Med J Aust. 1997 Nov 3;167(9):473-6. doi: 10.5694/j.1326-5377.1997.tb126674.x. Med J Aust. 1997. PMID: 9397061

4

Graft versus Burkitt's lymphoma effect after allogeneic marrow transplantation.

Grigg AP, Seymour JF. Grigg AP, et al. Leuk Lymphoma. 2002 Apr;43(4):889-92. doi: 10.1080/10428190290017051. Leuk Lymphoma. 2002. PMID: 12153181

5

Delayed-onset neutropenia associated with rituximab therapy.

Chaiwatanatorn K, Lee N, Grigg A, Filshie R, Firkin F. Chaiwatanatorn K, et al. Among authors: grigg a. Br J Haematol. 2003 Jun;121(6):913-8. doi: 10.1046/j.1365-2141.2003.04385.x. Br J Haematol. 2003. PMID: 12786803 Free article.

6

Autografting followed by rituximab for chemosensitive mantle cell lymphoma: a pilot study and literature review.

Grigg AP, Bashford J, Seymour JF, Shuttleworth P, Norris D, Hertzberg M, Gill D, Waugh M, Saal R, Marlton P. Grigg AP, et al. Leuk Lymphoma. 2005 Jun;46(6):851-60. doi: 10.1080/10428190500052461. Leuk Lymphoma. 2005. PMID: 16019529 Clinical Trial.

7

Late-onset pulmonary arterial hypertension in association with graft-versus-host disease after allogeneic stem-cell transplantation.

Grigg A, Buchanan M, Whitford H. Grigg A, et al. Am J Hematol. 2005 Sep;80(1):38-42. doi: 10.1002/ajh.20373. Am J Hematol. 2005. PMID: 16138351 Free article.

8

The hyper-CVAD-rituximab chemotherapy programme followed by high-dose busulfan, melphalan and autologous stem cell transplantation produces excellent event-free survival in patients with previously untreated mantle cell lymphoma.

Ritchie DS, Seymour JF, Grigg AP, Roberts AW, Hoyt R, Thompson S, Szer J, Prince HM. Ritchie DS, et al. Among authors: grigg ap. Ann Hematol. 2007 Feb;86(2):101-5. doi: 10.1007/s00277-006-0193-2. Epub 2006 Nov 7. Ann Hematol. 2007. PMID: 17089127 Clinical Trial.

9

Resolution of platelet function defects with imatinib therapy in a patient with chronic myeloid leukaemia in chronic phase.

Ng AP, Servadei P, Tuckfield A, Friedhuber A, Grigg A. Ng AP, et al. Among authors: grigg a. Blood Coagul Fibrinolysis. 2009 Jan;20(1):81-3. doi: 10.1097/MBC.0b013e3283177b03. Blood Coagul Fibrinolysis. 2009. PMID: 20523168

10

All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4).

Iland HJ, Bradstock K, Supple SG, Catalano A, Collins M, Hertzberg M, Browett P, Grigg A, Firkin F, Hugman A, Reynolds J, Di Iulio J, Tiley C, Taylor K, Filshie R, Seldon M, Taper J, Szer J, Moore J, Bashford J, Seymour JF; Australasian Leukaemia and Lymphoma Group. Iland HJ, et al. Among authors: grigg a. Blood. 2012 Aug 23;120(8):1570-80; quiz 1752. doi: 10.1182/blood-2012-02-410746. Epub 2012 Jun 19. Blood. 2012. PMID: 22715121 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

400 results

Search Page